Evidence map›Paper›PMID 30412228›Full record

ArticleJournal of Crohn's & colitis2019

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.

Julian Panés, Séverine Vermeire, James O Lindsay, Bruce E Sands, Chinyu Su, Gary Friedman, Haiying Zhang, Aaron Yarlas, Martha Bayliss, Stephen Maher and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of Crohn's & colitis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Observational
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Julian PanésHospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Séverine VermeireDepartment of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
James O LindsayCentre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Bruce E SandsDr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Chinyu SuPfizer Inc, Collegeville, PA, USA.
Gary FriedmanPfizer Inc, Collegeville, PA, USA.
Haiying ZhangPfizer Inc, Collegeville, PA, USA.
Aaron YarlasOptum, Lincoln, RI, USA.
Martha BaylissOptum, Lincoln, RI, USA.
Stephen MaherOptum, Lincoln, RI, USA.
Joseph C CappelleriPfizer Inc, Groton, CT, USA.
Andrew G BushmakinPfizer Inc, Groton, CT, USA.
David T RubinThe University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30412228
PMCPMC6302951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.